Industry Leaders Panel Discussion
Time: 9:00 am
day: Day One
• What have been the most exciting developments within the past 12 months?
• What does the path of approval and the commercialization of these products look like?
• If C.difficle and consortia-based therapeutics was the low-hanging fruit, what is the next area of microbiome research?
• How can the focus be turned to incorporating the patient first?
• What are the biggest challenges the field will face over the next 3 years?